Search

When Jacqueline was in pain caused by bone metastases from lung cancer, she got help at a specialized MSK clinic. "It's unbelievable the difference it made," she says.

… Thursday, October 3, 2024 For Jacqueline Hickey, the pain was so severe at times that it interfered with her daily life. “It just hurt so bad, especially lying down at night. I got so sleep deprived,” she recalls. “During the day, it was hard to even lift a laundry basket or walk for exercise.” She has

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, December 7, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Lisa DeAngelis Named to amNY Metro and PoliticsNY’s Power Players in Healthcare List Lisa DeAngelis Named to amNY Metro and PoliticsNY’s Power Players in Healthcare List Lisa

Join Jedd Wolchok, MD, PhD, during the June 24 edition of “MSK Science Spotlight” for a discussion on “Enabling Costimulatory Pathways as a Next Step for Cancer Immunotherapy.”

… Wednesday, June 24, 2020 Join Jedd Wolchok, MD, PhD, during the June 24 edition of “ MSK Science Spotlight ” for a discussion on “Enabling Costimulatory Pathways as a Next Step for Cancer Immunotherapy.” Dr. Wolchok serves as the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation

Moriyina Cole’s path to MSK started with a childhood in Sierra Leone, a move to Maryland when she was 15 years old, followed by time at Western Michigan University and Union Graduate College, where she received an undergraduate degree and a Master of Business Administration, respectively.

… Monday, March 28, 2022 Moriyina Cole’s path to MSK started with a childhood in Sierra Leone, a move to Maryland when she was 15 years old, followed by time at Western Michigan University and Union Graduate College, where she received an undergraduate degree and a Master of Business Administration, respectively

Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three clinical trials published in the New England Journal of Medicine. The landmark data support the foundation of precision oncology by creating a treatment option for a genetically defined cancer while continuing to validate the concept that comprehensive molecular profiling should be strongly considered in people of all ages with advanced solid tumors.

… Wednesday, February 21, 2018 Bottom Line: Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three clinical

Memorial Sloan Kettering Cancer Center and Summit Medical Group together announce a new collaborative relationship for the care of people with cancer.

… Thursday, October 2, 2008 Memorial Sloan Kettering Cancer Center (MSKCC) and Summit Medical Group (SMG) together announce a new collaborative relationship for the care of people with cancer. The initiative will give New Jersey residents who have cancer greater access to a broad array of services offered

MSK is helping young patients navigate their journey and get the best treatment through specialized counseling, digital connections, and more. “The gratitude I feel is so deep. I’m not just alive; I’m living,” says Desiree Allen.

… Friday, October 1, 2021 Before she was diagnosed with cancer in 2020 at age 31, Desiree Allen was living her best life. “I was in school part-time and working full-time, and I was — and still am — in a long-term relationship,” says the cardiology nurse, now 32. “As a matter of fact, I was having the

In this online discussion, panelists give tips for managing both your physical and mental well-being during the holiday season, especially against the backdrop of the ongoing pandemic.

… Tuesday, December 21, 2021 On Wednesday, December 15, 2021, a panel of Memorial Sloan Kettering Cancer Center (MSK) experts joined the Abyssinian Baptist Church in an online discussion that provided guidance and tips on staying mentally and physically healthy amid uncertainty, especially during this

Memorial Sloan Kettering Cancer Center (MSK) today announced that Kenneth Offit, MD, MPH, and Ross L. Levine, MD, have been elected as Fellows of the AACR Academy, one of the highest honors bestowed by the American Association for Cancer Research (AACR).

… Tuesday, January 27, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced that  Kenneth Offit, MD, MPH , and  Ross L. Levine, MD , have been elected as  Fellows of the AACR Academy, one of the highest honors bestowed by the  American Association for Cancer Research (AACR). Election to the

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

… Friday, July 6, 2012 Summary A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells. Doctors who treat patients with breast cancer have known that